Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Aquila BioMedical

Aquila BioMedical?uq=kzBhZRuG
2011 FOUNDED
M&A STATUS
Buyout/LBO LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Operator of a pre-clinical contract research organization. The company focuses on the development of therapeutics for oncology, biomarker discovery, and target expression, with services covering a wide range of in vitro and in vivo proof-of-concept studies in Scotland.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • Nine, Edinburgh BioQuarter
  • 9 Little France Road
  • Edinburgh EH16 4UX
  • Scotland

+44 0131 000 0000

Aquila BioMedical Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Aquila BioMedical‘s full profile, request access.

Request full access to PitchBook

Aquila BioMedical Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Aquila BioMedical‘s full profile, request access.

Request full access to PitchBook

Aquila BioMedical Executive Team (3)

Name Title Board
Seat
Contact
Info
Stephen Mark Anderton Co-Founder, Chief Scientific Officer & Director
Clare Louise Doris Vice President, Translational Biology & Board Member
Howard John Marriage Chairman & Co-Founder

Aquila BioMedical Board Members (4)

Name Representing Role Since Contact
Info
000000 000000 0000 000000000 Aquila BioMedical Board Member 000 0000
00000 000000 00000 Aquila BioMedical Vice President, Translational Biology & Board Member 000 0000
000000 0000 00000000 Self Chairman & Co-Founder 000 0000
00000 000000 000 00.0 Aquila BioMedical Board Member 000 0000